Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing […]
Hackensack Meridian Health and Google Expand Relationship to Improve Patient Care
Hackensack Meridian Health and Google today announced the two organizations are expanding their relationship to improve patient […]
Viome Life Sciences Announces Expansion of Collaboration with GSK into New Therapeutic Interventions for Cancers and Autoimmune Diseases
Viome Life Sciences, a mission-driven systems biology company aiming to help individuals improve their health, […]
Elevation Oncology Announces the Promotion of Valerie Malyvanh Jansen, M.D., Ph.D., to Chief Medical Officer
Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision […]
Healx Receives IND and Orphan Drug Designation for Fragile X Clinical Trial
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, is proud […]
Targovax ASA Appoints Dr. Erik Digman Wiklund as New CEO
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Novartis Awarded Promising Innovative Medicine Designation for Targeted Radioligand Theragnostics in Prostate Cancer
Novartis today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Promising […]
Horizon's Saint John Regional Hospital to Become Canada's First to Adopt Subtle Medical's AI Solutions
Subtle Medical, a healthcare technology company using artificial intelligence to improve medical imaging, announced today […]
Babylon Announces New Collaboration with Microsoft to Drive Healthcare Innovation and Improve Health Access and Affordability Around the World
Babylon, a world leading digital-first, value-based care company today announced a collaboration with Microsoft to […]
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
Aichi Cancer Center and Fujitsu Limited today announced the development of an AI solution able […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more